缺血性卒中预防中抗血小板药抵抗的应对策略  

Coping strategies for antiplatelet drug resistance in the prevention of ischemic stroke

作　　者：马启荣[1] 王雁[1] 

机构地区：[1]青岛大学附属医院神经内科,266021

出　　处：《国际脑血管病杂志》2017年第12期1123-1127,共5页International Journal of Cerebrovascular Diseases

摘　　要：阿司匹林和氯吡格雷被广泛应用于心脑血管病的防治。尽管部分患者接受抗血小板治疗，但仍会经历缺血性事件，这种现象被称为抗血小板药物抵抗。文章对缺血性卒中预防中抗血小板药物抵抗的应对策略进行了综述。Aspirin and clopidogrel are widely used in the prevention and treatment of cardiocerebro- vascular diseases. Although some patients have received antiplatelet therapy, they still experience ischemic events. This phenomenon is called antiplatelet drug resistance. This article reviews the coping strategies for antiplatelet drug resistance in the prevention of ischemic stroke.

关 键 词：卒中 脑缺血 抗血小板聚集药 阿司匹林 氯吡格雷 抗药性 

分 类 号：R743.3[医药卫生—神经病学与精神病学]